TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)

Clinical trial NCT02043847 · COMPLETED

Trial details

NCT number: NCT02043847
Sponsor: University of Illinois at Chicago
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma, Relapsed Multiple Myeloma, Refractory to Standard Treatment

Start date: 2014-01-14
Primary completion: 2016-09-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.